282 related articles for article (PubMed ID: 12370005)
1. PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways.
Zhou CJ; Shioda S; Yada T; Inagaki N; Pleasure SJ; Kikuyama S
Curr Protein Pept Sci; 2002 Aug; 3(4):423-39. PubMed ID: 12370005
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.
Arimura A
Jpn J Physiol; 1998 Oct; 48(5):301-31. PubMed ID: 9852340
[TBL] [Abstract][Full Text] [Related]
3. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
Hashimoto H
Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
[TBL] [Abstract][Full Text] [Related]
4. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.
Vaudry D; Gonzalez BJ; Basille M; Yon L; Fournier A; Vaudry H
Pharmacol Rev; 2000 Jun; 52(2):269-324. PubMed ID: 10835102
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain.
Shioda S
Kaibogaku Zasshi; 2000 Dec; 75(6):487-507. PubMed ID: 11197592
[TBL] [Abstract][Full Text] [Related]
7. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
8. PACAP in avians: origin, occurrence, and receptors--pharmacological and functional considerations.
Nowak JZ; Zawilska JB
Curr Pharm Des; 2003; 9(6):467-81. PubMed ID: 12570810
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.
Braas KM; May V
J Biol Chem; 1999 Sep; 274(39):27702-10. PubMed ID: 10488112
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms.
Braas KM; May V
Ann N Y Acad Sci; 1996 Dec; 805():204-16; discussion 217-8. PubMed ID: 8993404
[TBL] [Abstract][Full Text] [Related]
13. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
Maduna T; Lelievre V
J Neurosci Res; 2016 Dec; 94(12):1472-1487. PubMed ID: 27717098
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.
Harmar AJ; Fahrenkrug J; Gozes I; Laburthe M; May V; Pisegna JR; Vaudry D; Vaudry H; Waschek JA; Said SI
Br J Pharmacol; 2012 May; 166(1):4-17. PubMed ID: 22289055
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
17. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta.
Hezareh M; Schlegel W; Rawlings SR
J Neuroendocrinol; 1996 May; 8(5):367-74. PubMed ID: 8736436
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
D'Agata V; Cavallaro S; Stivala F; Canonico PL
Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons.
Olcese J; McArdle CA; Middendorff R; Greenland K
J Neuroendocrinol; 1997 Dec; 9(12):937-43. PubMed ID: 9468019
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]